Table 2.
Overview of mating-induced Fos and Meth-induced pERK expression in brain areas where sex and drugs activate non-overlapping neural populations.
Brain areas | Group | Fos | pERK | Dual | % Dual/pERK |
---|---|---|---|---|---|
Amygdala | |||||
CeA | Sal10 | 8.1 ± 2.0 | 33.7 ± 6.1 | 3.3 ± 0.8 | 11.1 ± 3.1 |
Sex+Sal10 | 22.9 ± 2.7* | 31.0 ± 5.7 | 13.9 ± 2.1* | 43.2 ± 4.3 | |
Meth10 | 10.3 ± 2.2 | 95.3 ± 8.3# | 5.1 ± 1.1 | 5.5 ± 1.6 | |
Sex+Meth10 | 21.6 ± 5.9* | 77.6 ± 6.6# | 17.3 ± 4.6* | 20.7 ± 4.6 | |
MEApd | Sal10 | 72.1 ± 13.5 | 40.2 ± 7.2 | 5.1 ± 1.9 | 11.4 ± 2.7 |
Sex+Sal10 | 295.3 ± 48.1* | 47.3 ± 6.7 | 13.8 ± 2.5* | 29.4 ± 1.1 | |
Meth10 | 99.1 ± 6.4 | 84.5 ± 11.1# | 9.1 ± 1.4 | 12.2 ± 2.2 | |
Sex+Meth10 | 403.5 ± 3.5*# | 56.5 ± 7.1 | 11.4 ± 0.5 | 21.3 ± 3.9 | |
BNST | |||||
BNSTpl | Sal10 | 19.9 ± 3.3 | 13.9 ± 5.9 | 2.5 ± 1.0 | 15.2 ± 5.4 |
Sex+Sal10 | 116.8 ± 14.9* | 6.8 ± 1.1 | 3.3 ± 0.8 | 49.3 ± 9.6 | |
Meth10 | 23.1 ± 1.7 | 35.4 ± 4.1# | 2.9 ± 0.6 | 8.6 ± 1.2 | |
Sex+Meth10 | 113.3 ± 16.5* | 20.6 ± 4.7* | 4.9 ± 1.1 | 24.5 ± 10.5 | |
mPFC | |||||
PL | Sal10 | 69.5 ± 13.4 | 31.5 ± 2.2 | 5.9 ± 2.1 | 17.9 ± 6.1 |
Sex+Sal10 | 168.6 ± 32.4* | 28.3 ± 1.6 | 12.0 ± 1.4* | 41.7 ± 4.9 | |
Meth10 | 70.9 ± 11.9 | 49.7 ± 2.4# | 8.1 ± 1.6 | 16.4 ± 3.3 | |
Sex+Meth10 | 148.1 ± 9.6* | 32.3 ± 3.5* | 13.0 ± 1.4 | 41.4 ± 5.9 | |
IL | Sal10 | 59.8 ± 7.9 | 31.9 ± 2.0 | 5.2 ± 1.6 | 15.8 ± 4.4 |
Sex+Sal10 | 129.8 ± 20.5* | 23.5 ± 2.9 | 9.3 ± 2.3 | 39.4 ± 3.6 | |
Meth10 | 62.9 ± 9.0 | 47.6 ± 2.7# | 6.1 ± 1.5 | 12.8 ± 3.3 | |
Sex+Meth10 | 108.5 ± 12.1* | 30.1 ± 2.6* | 8.3 ± 1.6 | 27.8 ± 3.7 |
Mean numbers ± of single and dual labeled neurons for pERK and Fos, as well as percentage of Meth activated neurons co-activated by sexual behavior are listed for each brain area for all four experimental groups.
indicate significant differences from unmated males of the same saline or Meth injected group (p < 0.05);
indicates significant differences from saline injected groups of the same sex or no sex treatment (p < 0.05).